Immunovia AB (publ) announced appointment of Nomination Committee for the 2023 Annual General Meeting . Based on the above, the Nomination Committee for the 2023 Annual General Meeting has been determined to consist of the following persons who together represent 13.46% of the number of shares and votes in the company as of September 30, 2022: Ranny Davidoff, representing Ranny Davidoff Carl Borrebaeck, Chairman of the Board, Peter Lindvall representing Mikael Löfman; and Mats Leifland, representing Mats Ohlin.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.452 SEK | -1.76% | +1.54% | -18.06% |
05-21 | Immunovia Seeks SEK70 Million from Proposed Rights Offering | MT |
04-29 | Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024 |
1st Jan change | Capi. | |
---|---|---|
-18.06% | 6.24M | |
-26.77% | 16.48B | |
-43.46% | 2.79B | |
+22.46% | 1.94B | |
-12.32% | 1.46B | |
+31.49% | 1.33B | |
-16.15% | 966M | |
+1.33% | 791M | |
-31.07% | 788M | |
-25.95% | 620M |
- Stock Market
- Equities
- IMMNOV Stock
- News Immunovia AB
- Immunovia AB Announces Appointment of Nomination Committee for the 2023 Annual General Meeting